Article information
Full text is only aviable in PDF
REFERENCES
[1]
F Serrano Muñoz, M Casillas, F García Lax, A Alix Trueba, C Rivas.
Trasplantes experimentales de pulmón.
Rev Clin Esp, 87 (1963), pp. 163-167
[2]
JM Borro, F Ramos, R Vicente, F Sanchís, P Morales, JM Cafarena.
Bronchial fistula to the mediastinum in a heart-lung transplant patient.
Eur J Cardiothorac Surg, 6 (1992), pp. 674-676
[3]
A Román, F Morell, J Astudillo, C Margarit, C Bravo, L Tenorio, y Grupo de Trasplante Pulmonar del HVH, et al.
Trasplante unipulmonar: los dos primeros casos.
Med Clin (Barc), 100 (1993), pp. 380-383
[4]
J Astudillo, C Bravo, C Margarit, MI Guillermo, L Tenorio, y Grupo de Trasplante Pulmonar.
Trasplante bipulmonar secuencial. Técnica y resultados de los tres primeros casos.
Arch Bronconeumol, 30 (1994), pp. 348-353
[5]
JM Borro, V Calvo, P Morales, P Morant, G Sales, J Ferrer.
El trasplante pulmonar en la fibrosis quística.
An Esp Pediatr, 45 (1996), pp. 505-510
[6]
JM Borro, P Morales, C Lozano, V Tarrazona, P Morant, G Galán, et al.
1990-1996, experiencia del Grupo de Trasplante Pulmonar de La Fe-Valencia.
Arch Bronconeumol, 33 (1997), pp. 438-443
[7]
MT Lazaro, P Ussetti, MJ Ferreiro, MC Carreño, A Pablo, F García, et al.
Supervivencia del trasplante pulmonar en la Clínica Puertade Hierro.
Arch Bronconeumol, 34 (1998), pp. 285-288
[8]
EP Trulock, LB Edwards, DO Taylor, MM Boucek, BM Keck, MI Hertz.
The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report-2004.
J Heart Lung Transplant, 23 (2004), pp. 804-815
[9]
JM Borro, M de la Torre, C Bonome, I Otero, C Míguelez, F Refojo, et al.
Segunda generación de grupos de trasplante pulmonar: experiencia inicial de la comunidad gallega.
Arch Bronconeumol, 36 (2000), pp. 39
[11]
AR Glanville, M Estenne.
Indications, patient selection and timing of referral for lung transplantation.
Eur Respir J, 22 (2003), pp. 845-852
[12]
A de Pablo, P Morales, A Román, R Lama, F García López, JM Borro, et al.
EPOC y trasplante pulmonar: resultados en España.
Arch Bronconeumol, 35 (1999), pp. 334-338
[13]
JM Borro, V Calvo, P Morales, P Morant, A Morcillo, V Tarazona.
Clinical experience on lung transplantation for treatment of cystic fibrosis advance stage.
Transplantology, 3 (1998), pp. 63-66
[14]
MT Lázaro-Carrasco, P Morales, MJ Ferreiro, JM Borro, A Varela, R Vicente, et al.
Trasplante pulmonar en la fibrosis quística.
Rev Clin Esp, 199 (1999), pp. 280-284
[15]
M Magulkoc, MH Brutsche, PW Bishop, M Greaves, A Horrocks, JJ Egan.
Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.
Am J Respir Crit Care Med, 164 (2001), pp. 103-108
[16]
J Gaudo, A Pacheco, L Máiz.
Actualización de criterios para trasplante pulmonar en la fibrosis pulmonar idiopática.
Arch Bronconeumol, 38 (2002), pp. 251-252
[17]
T Higenbottam, AY Butt, A McMahon, R Westerbeck, L Sharples.
Long-term intravenous prostaglandin for treatment of severe pulmonary hypertension.
Heart, 80 (1998), pp. 151-155
[18]
O Sitbon, M Humbert, H Nunes, F Parent, G García, P Herve, et al.
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension.
J Am Coll Cardiol, 40 (2002), pp. 780-788
[19]
H Olschewski, G Simonneau, N Galie, T Higenbottam, R Naeije, LJ Rubin, et al.
Inhaled iloprost for severe pulmonary hypertension.
N Engl J Med, 347 (2002), pp. 322-329
[20]
LJ Rubin, DB Badesch, RJ Barst, N Galie, CM Black, A Keogh, et al.
Bosentan therapy for pulmonary arterial hypertension.
N Engl J Med, 346 (2002), pp. 896-903
[21]
A Rothman, MS Sklansky, VW Lucas, IA Kazan, RD Shaughnessy, RN Channick, et al.
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension.
Am J Cardiol, 84 (1999), pp. 682-686
[22]
C Prados, L Máiz, C Antelo, F Baranda, J Blázquez, JM Borro, et al.
Fibrosis quística: consenso sobre el tratamiento del neumotórax y de la hemoptisis masiva y sobre las indicaciones del trasplante pulmonar.
Arch Bronconeumol, 36 (2000), pp. 411-416
[23]
JR Maurer, AE Frost, M Estenne, T Higenbottam, AR Glanville.
International guidelines for the selection of lung transplant candidates.
Transplantation, 66 (1998), pp. 951-956
[24]
Grupo de trabajo de la SEPAR.
Normativa SEPAR. Trasplante pulmonar.
Arch Bronconeumol, 37 (2001), pp. 307-315
[25]
A Álvarez, R Lama, J Algar, F Santos, J Briceño, JL Aranda, et al.
Predicting mortality after lung transplantation.
Transplant Proc, 33 (2001), pp. 1630-1631
[26]
GL Zorn Jr, DC McGiffin, KR Young Jr, CB Alexander, D Weill, JK Kirklin.
Pulmonary transplantation for advanced bronchioloalveolar carcinoma.
J Thorac Cardiovasc Surg, 125 (2003), pp. 20-22
[27]
P Morales, D Hernández, R Vicente, A Solé, I Moreno, JJ Torres, et al.
Lung transplantation in patients with x-linked agammaglobulinemia.
Transplant Proc, 35 (2003), pp. 1942-1943
[28]
Y Shargall, S Pakhale, D Chamberlain, A Pierre, T Waddeil, M Hutcheon, et al.
Bilateral lung transplantation for metastatic leiomyosarcoma.
J Heart Lung Transplant, 23 (2004), pp. 912-915
[29]
FJ Algar, A Álvarez, R Lama, A Santos, JL Aranda, C Baamonde, et al.
Lung transplantation in patients under mechanical ventilation.
Transplant Proc, 35 (2003), pp. 737-738
[30]
V Calvo, J Padilla, A García-Zarza, E Blasco, J Pastor, F París.
El trasplante pulmonar en situación de urgencia.
Arch Bronconeumol, 39 (2003), pp. 111-114
[31]
B Miranda, R Matesanz, M Fernández Lucas, MT Naya, C Felipe.
Organ donation in Spain: evolution of organ donor characteristics.
Transplantation Proc, 28 (1996), pp. 175-176
[32]
AM Ciccone, BF Meyers, TJ Guthrie, RJ Battafarano, EP Trulock, JD Cooper, et al.
Does donor cause of death affect the outcome of lung transplantation.
J Thorac Cardiovasc Surg, 123 (2002), pp. 429-436
[33]
C Aigner, G Seebacher, W Kepletko.
Donor selection.
Chest Surg Clin N Am, 13 (2003), pp. 429-442
[34]
A Álvarez, FJ Algar, F Santos, R Lama, C Baamonde, JL Aranda, et al.
The donor lung assessment: experience of the Reina Sofía Hospital.
Transplant Proc, 35 (2003), pp. 739-741
[35]
S Sunderesan, J Semenkovich, L Ochoa.
Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs.
J Thorac Cardiovasc Surg, 109 (1995), pp. 1075-1080
[36]
J Padilla, V Calvo, J Teixidor, A Varela, M Carbajo, A Álvarez.
Pulmonary “twinning” transplantation procedure.
Transplant Proc, 34 (2002), pp. 1287-1289
[37]
BF Meyers, J Lynch, EP Trulock, TJ Gutric, JD Cooper, GA Patterson.
Lung transplantation: a decade of experience.
Ann Surg, 230 (1999), pp. 362-370
[38]
S Steen, T Sjoberg, L Pierre, Q Liao, L Eriksson, L Algotsson.
Transplantation of lung from a non-heart-beating donor.
Lancet, 357 (2001), pp. 825-829
[39]
JR Núñez, A Varela, F del Río, P Gámez, J Calatayud, M Córdoba, et al.
Bipulmonary transplants with lungs obtained from two non-heart-beating donors who died out of hospital.
J Thoracic Cardiovasc Surg, 127 (2004), pp. 297-299
[40]
VA Starnes, ME Bowdish, MS Woo, RG Barbers, FA Schenkel, MV Horn, et al.
A decade of living lobar lung transplantation: recipient outcomes.
J Thorac Cardiovasc Surg, 127 (2004), pp. 114-122
[41]
JA Couetil, MJ Tolan, DF Loulmet.
Pulmonary bipartitioning and lobar transplantation: a new approach to donor organ shortage.
J Thorac Cardiovasc Surg, 113 (1997), pp. 529-537
[42]
M Perrot, S Keshavjee.
Lung preservation.
Chest Surg Clin N Am, 13 (2003), pp. 433-462
[43]
AM Padilla, JD Padilla.
Estado actual de la preservación pulmonar.
Arch Bronconeumol, 40 (2004), pp. 86-93
[44]
SH Keshavjee, F Yamazaki, PF Cardoso, DI McRitchie, GA Patterson, JD Cooper.
A method for safe twelve-hour pulmonary preservation.
J Thorac Cardiovasc Surg, 98 (1989), pp. 529-534
[45]
H Date, A Matsumura, JK Manchester, H Obo, O Lima, JM Cooper, et al.
Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation.
J Thorac Cardiovasc Surg, 105 (1993), pp. 480-491
[46]
M Struber, JM Hohlfeld, S Fraund, P Kim, G Warnecke, A Haverich.
Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function.
J Thorac Cardiovasc Surg, 120 (2000), pp. 566-572
[47]
JM Rabanal, AM Ibáñez, R Mons, AM González, M Carbajo, J Ortega, et al.
Influence of preservation solution on early lung function.
Transplant Proc, 35 (2003), pp. 1938-1939
[48]
MA Sarsam, NA Donan, AK Deiranika, AN Rahman.
Retrograde pulmonary plegia for lung preservation in clinical transplantation: a new technique.
J Heart Lung Transplant, 12 (1993), pp. 494-498
[49]
A Varela, CG Montero, M Córdoba, A Antequera, M Pérez, MJ Tabuenca, et al.
Improved distribution of pulmonary flush solution to the tracheobronchial wall in pulmonary transplantation.
Eur Surg Res, 29 (1997), pp. 1-4
[50]
A Varela, C Montero, M Córdoba, S Serrano-Fiz, R Burgos, JC Téllez, et al.
Clinical experience with retrograde lung preservation.
Transp Int, 9 (1996), pp. S296-S2S8
[51]
F Venuta, EA Rendina, M Bufi, et al.
Preimplantation retrograde pneumoplegia in clinical lung transplantation.
J Thorac Cardiovas Surg, 118 (1999), pp. 107-114
[52]
A Varela, M Córdoba, S Serrano-Fiz, R Burgos, C Montero, JC Téllez, et al.
Early lung allograft function after retrograde and anterograde preservation.
J Thorac Cardiovasc Surg, 114 (1997), pp. 1119-1120
[53]
A Álvarez, A Salvatierra, R Lama, J Algar, F Cerezo, F Santos.
Preservation with a retrograde second flushing of Eurocollins in clinical lung transplantation.
Transplant Proc, 31 (1999), pp. 1088-1090
[54]
JM Borro, V Tarrazona, G Galán, V Calvo, C Lozano, P Morant, y Grupo de Trasplante Pulmonar de La Fe, et al.
Ampliando indicaciones en el trasplante bipulmonar secuencial.
Arch Bronconeumol, 35 (1999), pp. 129-135
[55]
SD Cassivi, BF Meyers, RJ Battafarano.
Thirteen-year experience in lung transplantation for emphysema.
Ann Thorac Surg, 74 (2002), pp. 1663-1669
[56]
HP McAdams, JJ Erasmus, SM Palmer.
Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: incidence, radiologic features, and clinical importance.
Radiology, 218 (2001), pp. 233-241
[57]
F Venuta, A Boehler, EA Rendina, T de Giacomo, R Speich, R Schmid.
Complications in the native lung after single lung transplantation.
Eur J Cardiothorac Surg, 16 (1999), pp. 54-58
[58]
D Weill, F Torres, TN Hodges, JJ Olmos, MR Zamora.
Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema.
J Heart Lung Transplant, 18 (1999), pp. 1080-1087
[59]
A Khaghani, KM Al-Kattan, S Tadjkarimi, N Banner, M Yacoub.
Early experience with single lung transplantation for emphysema with simultaneous volume reduction of the contralateral lung.
Eur J Cardiothorac Surg, 11 (1997), pp. 604-608
[60]
M Estenne, M Cassart, P Poncelet, PA Gevenois.
Volume of graft and native lung after single-lung transplantation for emphysema.
Am J Respir Crit Care Med, 159 (1999), pp. 641-645
[61]
NA Yonan, A El-Gamel, J Egan, J Kakadellis, A Rahman, AK Deiraniya.
Single lung transplantation for emphysema: predictors for native lung hyperinflation.
J Heart Lung Transplant, 17 (1998), pp. 192-201
[62]
MB Anderson, JM Kriett, DP Kapelanski, A Perricone, CM Smith, SW Jamieson.
Volume reduction surgery in the native lung after single lung transplantation for emphysema.
J Heart Lung Transplant, 16 (1997), pp. 752-757
[63]
JB Mitchell, AD Shaw, S Donald, JG Farrimond.
Differential lung ventilation after single-lung transplantation for emphysema.
J Cardiothorac Vasc Anesth, 16 (2002), pp. 459-462
[64]
CL Lau, GA Patterson.
Current status of lung transplantation.
Eur Respir J, 22 (2003), pp. 57S-64S
[65]
P Morales, L Almenar, JJ Torres, A Solé, R Vicente, F Ramos, et al.
Cardiopulmonary transplantation: experience of a lung transplant group.
Transplant Proc, 35 (2003), pp. 1954-1956
[66]
FJ Veith, C Montefusco, SL Kamlolz, FP Mollenkopf.
Lung transplantation.
Heart Transplant, 2 (1983), pp. 155-156
[67]
FG Pearson.
Lung transplantation: the Toronto experience.
Eur J Cardiothorac Surg, 3 (1989), pp. 6-11
[68]
JD Cooper, FG Pearson, GA Patterson, TRJ Todd, RJ Ginsberg, M Goldgerg, et al.
Technique of successful lung transplantation in humans.
J Thorac Cardiovasc Surg, 93 (1987), pp. 173-181
[69]
GA Patterson, JD Cooper, B Goldman, RD Weisel, FG Pearson, PF Waters, et al.
Technique of successful clinical double-lung transplantation.
Ann Thorac Surg, 45 (1988), pp. 626-633
[70]
CL Lau, GA Paterson.
Technical consideration in lung transplantation.
Chest Surg Clin N Am, 13 (2003), pp. 463-483
[71]
BK Meyers, RS Sundaresan, T Guthrie, JD Cooper, GA Patterson.
Bilateral sequential lung transplantation without sternal division eliminates posttransplantation sternal complications.
J Thorac Cardiovascular Surg, 117 (1998), pp. 358-364
[72]
A Varela, C Montero, E Castedo, J Roda, P Gámez, L Madrigal, et al.
Transcutaneous extracorporeal cannulation for bilateral lung transplantation without splitting the sternum.
J Torac Cardiovasc Surg, 1 19 (2000), pp. :402-:403
[73]
FJ Gómez, A Planas, P Ussetti, JJ Tejada, A Varela.
Factores pronósticos de morbimortalidad temprana en el trasplante pulmonar.
Arch Bronconeumol, 39 (2003), pp. 353-360
[74]
RF Nelly.
Current strategies in lung preservation.
J Lab Clin Med, 136 (2000), pp. 427-440
[75]
J Rabanal, R Mons, F Zurbano, I Ruiz, J Alcíbar, J Ortega.
Edema postimplante en el trasplante pulmonar. Isquemia-reperfusión o edema hidrostático.
Rev Esp Anestesiol Reanim, 48 (2001), pp. 146-150
[76]
G Thabut, I Vinatier, O Brugière, G Lesèche, P Loirat, A Bisson, et al.
Influence of preservation solution on early graft failure in clinical lung transplantation.
Am J Respir Crit Care Med, 164 (2001), pp. 1204-1208
[77]
M Strüber, M Wihlemi, W Harringer, J Niedemeyer, M Anssar, A Kunseberck, et al.
Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation.
Eur J Cardiothorac Surg, 19 (2001), pp. 190-194
[78]
S Fischer, A Matte-Martyn, M de Parrot, T Waddell, Y Sekine, M Hutcheon, et al.
Low-potassium dextran preservation solution improves lung function alter lung transplantation.
J Thorac Cardiovasc Surg, 120 (2001), pp. 594-596
[79]
A Salvatierra, R Guerrero, M Rodríguez, A Álvarez, F Soriano, R López-Pedrera, et al.
Antithrombin III prevents early pulmonary dysfunction alter lung transplantation in the dog.
Circulation, 11 (2001), pp. 2975-2980
[80]
L Couraud, SAM Nashef, P Nicolini, J Jougon.
Classification of airway anastomotic healing.
Eur J Cardiothorac Surg, 6 (1992), pp. 496-497
[81]
A Álvarez, A Algar, F Santos, Lamar, JL Aranda, C Baamonde, et al.
Airway complications alter lung transplantation: a review of 151 anastomoses.
Eur J Cardiothorac Surg, 19 (2001), pp. 381-387
[82]
T Hasegawa, AT Iacono, PD Orons, SA Yousem.
Segmental nonanastomotic bronchial stenosis after lung transplantation.
Ann Thoracic Surg, 69 (2000), pp. 1020-1024
[83]
PM Hopkins, CL Aboyoun, PN Chhajed, MA Malouf, ML Plit, SP Rainer, et al.
Prospective analysis of 1235 transbronchial lung biopsies in lung transplant recipients.
J Heart Lung Transplant, 21 (2002), pp. 1062-1067
[84]
MM Chakinala, EP Trulock.
Acute allograft rejection after lung transplantation: diagnosis and therapy.
Chest Surg Clin N Am, 13 (2003), pp. 525-542
[85]
T Hasegawa, AT Iacono, SA Yousem.
The anatomic distribution of acute cellular rejection in the allograft lung.
Ann Thorac Surg, 69 (2000), pp. 1529-1531
[86]
SA Yousem, GJ Berry, PT Cagle, D Chamberlain, AN Husain, RH Hruban, et al.
Revision of 1990 Working Formulation for the classification of pulmonary allograft rejection.
J Heart Lung Transplant, 15 (1996), pp. 1-15
[87]
D Slebos, DS Postma, GH Koëter, W van der Bij, M Boezen, HF Kauffman.
Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
J Heart Lung Transplant, 23 (2004), pp. 532-540
[88]
SM Studer, JB Orens, I Rosas, JA Krishnan, KA Cope, S Yang, et al.
Patterns and significance of exhaled biomarkers in lung transplant recipients with acute allograft rejection.
J Heart Lung Transplant, 20 (2001), pp. 1 158-1 166
[89]
VG Valentine, DE Taylor, GS Dhillon, MT Knower, PM McFadden, DM Fuchs, et al.
Success of lung transplantation without surveillance bronchoscopy.
J Heart Lung Transplant, 21 (2002), pp. 319-326
[90]
MA Baz, DT Layish, JA Govert, DN Howell, CM Lawrence, RD Davis, et al.
Diagnostic yield of bronchoscopies after isolated lung transplantation.
Chest, 110 (1996), pp. 84-88
[91]
LD Sharples, K McNeil, S Stewart, J Wallwork.
Risk factors for bronchiolitis obliterans: a systematic review of recent publications.
J Heart Lung Transplant, 21 (2002), pp. 271-281
[92]
D Heng, LD Sharples, K McNeil.
Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
J Heart Lung Transplant, 17 (1998), pp. 1255-1263
[93]
R Lama, F Santos, FJ Algar, A Álvarez, C Baamonde.
Lung transplants with tacrolimus and mycophenolate mofetil: a review.
Transplant Proc, 35 (2003), pp. 1968-1973
[94]
A Zuckermann, H Reichenspurner, T Birsan, H Treede, E Deviatko, Reichart, et al.
Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as immunosuppression after lung transplantation.
J Thoracic Cardiovasc Surgery, 125 (2003), pp. 891-900
[95]
A Zuckerman, W Klepetko, T Birsan, et al.
Comparison between mycophenolate mofetil and azathioprine-based immunosuppressions in clinical lung transplantation.
J Heart Lung Transplant, 18 (1999), pp. 432-440
[96]
SM Palmer, AP Miralles, CM Lawrence, JW Gaynor, RD Davis, VF Tapson.
Rabbit antithymocyte globulin decrease acute rejection after lung transplantation: result of a randomized, prospective study.
Chest, 116 (1999), pp. 127-133
[97]
ER Garrity, J Villanueva, SM Bhorade, AN Husain, WT Vigneswaran.
Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody.
Transplantation, 71 (2001), pp. 773-777
[98]
MV Brock, MC Borja, L Ferber, JB Orens, RA Anzcek, J Krishnan, et al.
Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte antibody and daclizumab.
J Heart Lung Transplant, 20 (2001), pp. 1282-1290
[99]
AT Iacono, BA Johnson, T Corcoran, DA Smith, WF Grgurich, JH Dauber, et al.
A randomized trial of early administration of inhaled cyclosporine in lung transplant recipients.
J Heart Lung Transplant, 23 (2004), pp. S175
[100]
MC Carreño, P Ussetti, A Varela, P Mendaza, R Daza, MJ Ferreiro, et al.
Infección en el trasplante pulmonar.
Arch Bronconeumol, 32 (1996), pp. 442-446
[101]
JM Borro, R Vicente, V Tarazona, F París, M Gobernado.
Aproximación a la infección bacteriana en el trasplante pulmonar.
Rev Clin Esp, 195 (1995), pp. 22-26
[102]
RM Aris, JC Routh, JJ Li Puma, DG Heath, PH Gilligan.
Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex.
Am J Respir Crit Care Med, 164 (2001), pp. 2102-2106
[103]
A de Soyza, A McDowell, L Archer, JH Dark, SJ Elborn, E Mahenthiralingam, et al.
Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patines with cystic fibrosis.
Lancet, 358 (2001), pp. 1780-1781
[104]
AR Glanville, VG Valentine, CL Aboyoun, MA Malouf.
CMV mismatch is not a risk factor for survival or severe bronchiolitis obliterans syndrome alter lung transplantation.
J Heart Lung Transplant, 23 (2004), pp. S43
[105]
RM Kruger, S Paranjothi, GA Storch, JP Lynch, EP Trulock.
Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients.
J Heart Lung Transplant, 22 (2003), pp. 754-763
[106]
V Monforte, A Román, J Gavaldá, R López, L Pou, M Simó, et al.
Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients.
Transplantation, 75 (2003), pp. 1571-1574
[107]
V Monforte, A Román, J Gavaldá, C Bravo, L Tenorio, A Ferrer, et al.
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors.
J Heart Lung Transplant, 20 (2001), pp. 1274-1281
[108]
V Calvo, JM Borro, V Tarazona, A Morcillo, F París.
Antifungal prophylaxis in early postoperative period in lung transplantation.
Chest, 115 (1999), pp. 1301-1304
[109]
J Ferrer, J Roldán, A Román, C Bravo, V Monforte, et al.
Acute and chronic pleural complications in lung transplantation.
J Heart Lung Transplant, 22 (2003), pp. 1217-1225
[110]
JD Cooper, M Billingham, T Egan, et al.
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts.
J Heart Lung Transplant, 12 (1993), pp. 713-716
[111]
S Yousem.
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
J Heart Lung Transplant, 21 (2002), pp. 297-310
[112]
D Hadjiliadis, R Duane Davis, MP Steele, RH Messier, CL Lau, SS Eubanks, et al.
Gastroesophageal reflux disease in lung transplant recipients.
Clin Transplant, 17 (2003), pp. 363-368
[113]
MG Hartwig, E Cantu, JZ Appel, H Woreta, SM Palmer, RD Davis.
Non alloimmune injury mediated by gastroesophageal reflux precipitates alloimmune injury in lung transplant patients.
J Heart Lung Transplant, 23 (2004), pp. S43
[114]
AJ Fisher, E Gabbay, T Small, S Doig, JH Dark, PA Corris.
Cross sectional study of exhaled nitric oxide levels following lung transplantation.
Thorax, 53 (1998), pp. 454-458
[115]
GM Verleden, M Delacroix, B Buyse, L Dupont, Leuven Lung Transplant Group.
Exhaled NO after lung transplantation; a prospective study.
J Heart Lung Transplant, 20 (2001), pp. 208
[116]
PA Corris.
Bronchiolitis obliterans syndrome.
Chest Surg Clin N Am, 13 (2003), pp. 543-557
[117]
R Lama, A Álvarez, F Santos, J Algar, JL Aranda, C Baamonde, et al.
Long-term result of lung transplantation for cystic fibrosis.
Transplant Proc, 33 (2001), pp. 1624-1625
[118]
A Álvarez, R Lama, J Algar, F Santos, J Briceno, JL Aranda, et al.
Predicting mortality after lung transplantation.
Transplant Proc, 33 (2001), pp. 1630-1631
[119]
MM Limbos, DP Joyce, CK Chan, S Kesten.
Psychological functioning and quality of life in lung transplant candidates and recipients.
Chest, 118 (2000), pp. 408-416
[120]
EM Ten Vergertert, KM Vermeulen, A Geertsma, et al.
Quality of life before and after lung transplantation in patients with emphysema versus other indications.
Psychol Rep, 89 (2001), pp. 707-717
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
